Your first paragraph $””””””” is very pertinent, the question then becomes, - what is Biotron going to do next if there is no commercial deal outcome?. It has to have something going on to remain relevant to SHs. I can’t imagine “working on the next gen HIV drug” will cut the mustard with already weary SHs, and the hep B program hasn’t done anything in years.
BIT Price at posting:
8.2¢ Sentiment: None Disclosure: Not Held
